News und Analysen
Poxel Reports Cash and Revenue for the First Quarter 2023 and Provides Corporate Update
Regulatory News:
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic
Poxel Announces Notice of Its Annual General Meeting to Be Held on June 21, 2023
Regulatory News:
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic
Poxel Announces TWYMEEG® (Imeglimin) Fiscal Year 2022 Sales
Regulatory News:
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic
EQS-News: Abivax announces its ordinary and extraordinary general meeting of June 5, 2023, and the availability of the preparatory documents
IC.IDO Weave der ESI Group beschleunigt die Produktentwicklung und die Entscheidungsfindung in Unternehmen im industriellen Metaverse
ESI Group (ISIN Code: FR0004110310, Symbol: ESI), ein führender Anbieter von Simulations- und Virtual Prototyping-Software für Branchen weltweit, hat die Einführung von IC.IDO Weave bekannt
ESI Group’s IC.IDO Weave Accelerates Product Development and Enterprise Decision-making in the Industrial Metaverse
Regulatory News:
ESI Group (ISIN Code: FR0004110310, Symbol: ESI), a leading simulation and virtual prototyping software provider for industries worldwide, has announced the launch of IC.IDO
Poxel Announces Upcoming Participation at the JMP Securities Life Science Conference
Regulatory News:
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic
Transgene provides business update and Q1 2023 financial position
Regulatory News:
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today provides a business update, including
GEVELOT S.A.: Weekly report of share buyback May 10, 2023
Kaufman & Broad SA: RESULT OF VOTES OF THE ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING OF MAY 4, 2023
Transgene - First Patient Dosed in Phase I Trial Evaluating TG6050, a Novel IL-12-Armed Oncolytic Virus Administered Intravenously, in Non-Small Cell Lung Cancer
Regulatory News:
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announced that the first patient has been
Verimatrix präsentiert Streamkeeper, VCAS und XTD-Lösungen auf der CABSAT und ANGA COM
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), der führende Anbieter von Sicherheitstechnologien für die moderne vernetzte Welt, gab heute bekannt, dass das Unternehmen seine bahnbrechenden Video-
Verimatrix To Highlight Streamkeeper, VCAS and XTD Solutions at CABSAT and ANGA COM
Regulatory News:
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced it’s scheduled to showcase its
Transgene’s Combined General Meeting of May 5, 2023
Regulatory News:
The Combined Ordinary and Extraordinary General Meeting of Transgene’s (Paris:TNG) shareholders was held today (May 5, 2023) at 9:00 a.m. at the Company’s headquarters (400
Kaufman & Broad SA: DESCRIPTION OF THE SHARE REPURCHASE PROGRAM 2023
Transgene Announces New Leadership Structure to Accelerate the Development of its Innovative Immunotherapy Portfolio
Regulatory News:
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, announced that the Board has appointed Dr Alessandro
EQS-News: Abivax publishes Universal Registration Document 2023 “Document d’Enregistrement Universel”
Kaufman & Broad SA: DIVIDEND PAYMENT IN RESPECT OF THE FINANCIAL YEAR ENDED NOVEMBER 30, 2022
GEVELOT S.A.: Weekly report of share buyback May 3, 2023
Verimatrix Wins 2023 NAB Show Product of the Year Award
Regulatory News:
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced that Verimatrix Streamkeeper was
Verimatrix To Demo New App Security Technology at 2023 RSA Conference
Regulatory News:
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced it will demo its latest
Verimatrix präsentiert neue Sicherheitstechnologie-App auf der RSA Conference 2023
Verimatrix, der führende Anbieter von Sicherheitslösungen für die moderne vernetzte Welt, kündigte heute an, dass er auf seine neueste Verimatrix XTD UX und Design auf der diesjährigen RSA
Verimatrix XTD Wins 2023 Global Infosec Award
Regulatory News:
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced that Verimatrix XTD (Extended
New Data Showing that Transgene and NEC’s Individualized Cancer Vaccine TG4050 Induces Strong and Specific Immune Responses against Tumors Presented at AACR 2023
Regulatory News:
Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Corporation (NEC; TSE:
Poxel Announces Multiple TWYMEEG® (Imeglimin) Abstracts Accepted for Oral Presentation
Regulatory News:
POXEL SA (Euronext: POXEL - FR0012432516) (Paris:POXEL), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic